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Introduction
============

Heart function, in particular the rhythm (chronotropy) and force of contraction (inotropy), is regulated by β-adrenoceptors and muscarinic type 2 (M2)[\*](#fn1){ref-type="fn"} receptor--mediated activation/inhibition of L-type Ca^2+^ current (I~Ca~) (chronotropy and inotropy) and acetylcholine-activated K^+^ current (I~K,ACh~) (chronotropy) ([@bib28]). The signaling cascade involved in the modulation of I~Ca~ has been described in detail (for review see [@bib34]). In vivo ([@bib25]) and in vitro studies have suggested that pertussis toxin sensitive G proteins of the G~i~ family mediate muscarinic depression of I~Ca~ ([@bib41]; [@bib44]; [@bib3]) and activation of I~K,ACh~ ([@bib32]). The involvement of NO in M2 receptor--mediated depression of I~Ca~ in adult heart is controversial ([@bib11]; [@bib36]). We previously demonstrated that the mechanism of muscarinic regulation of I~Ca~ switches during embryonic development from a NO-mediated depression of basal I~Ca~ to direct G~i~-mediated lowering of adenylyl cyclase (AC) activity in late stage cardiomyocytes ([@bib18]).

Given that cytoskeleton-associated membrane receptors have been implicated in several heart disorders (for review see [@bib33]), we determined whether β1 integrin receptors modulate ionic conductances critical for heart function. Since β1 integrin^−/−^ mice died shortly after implantation, chimeric mice or in vitro differentiated embryonic stem (ES) cell--derived β1 integrin^−/−^ cells ([@bib9]) were used. Previous studies revealed several abnormalities in β1 integrin--deficient cells including migration and homing defects of haematopoietic cells ([@bib14]), alterations in vasculo- and angiogenesis ([@bib2]), and severely disturbed cardiomyogenesis ([@bib9]). Although the biophysical characteristics of ionic conductances of β1 integrin^−/−^ ES cell--derived cardiomyocytes appeared normal, the action potentials generated by deficient cardiomyocytes exhibited a primitive phenotype at all stages of differentiation ([@bib9]). Furthermore, β1 integrin^−/−^ ES cell--derived cardiomyocytes exhibited abnormalities in cytoskeletal integrity. Herein, we investigated the role of β1 integrins in hormonal regulation of I~Ca~ using β1 integrin^−/−^ cardiomyocytes.

We report that β1 integrin^−/−^ cardiomyocytes lacked muscarinic signaling, whereas β-adrenoceptor--mediated stimulation of I~Ca~ remained intact. This specific signaling defect was found to be related to spatial displacement of G proteins of the G~i~-family.

Results
=======

Muscarinic depression of basal I~Ca~ was found to be absent in **β**1 integrin***^−^*** ^/**−**^ ES cell--derived cardiomyocytes
--------------------------------------------------------------------------------------------------------------------------------

As previously reported ([@bib18]), prominent inhibition (44.7 ± 8%; [Fig. 1](#fig1){ref-type="fig"} d) of basal I~Ca~ density was observed upon application of the muscarinic agonist carbachol (CCh) (1 μM) ([Fig. 1](#fig1){ref-type="fig"} a) in a large percentage of early developmental stage (EDS) cardiomyocytes (69%, *n* = 13; [Fig. 1](#fig1){ref-type="fig"} c). Similarly, in the β1 integrin^+/−^ ES cell--derived EDS cardiomyocytes, basal I~Ca~ density was depressed in half of the cells tested by 44 ± 8% (*n* = 10). In contrast, β1 integrin^−/−^ cells did not exhibit CCh-mediated inhibition of basal I~Ca~ (*n* = 37) ([Fig. 1, b, c, and e](#fig1){ref-type="fig"}). To rule out that a shift in the voltage dependence of I~Ca~ underlies the CCh effect after the step to 0 mV, the current--voltage (I/V) relationship was defined in the presence and absence of CCh (*n* = 5). As depicted in [Fig. 1](#fig1){ref-type="fig"} f, no CCh-mediated depression of I~Ca~ was observed at the chosen potentials.

![**Muscarinic modulation of basal I~Ca~ is absent in** β**1 integrin** ^−^ **/**− **ES cell--derived cardiomyocytes.** (a) Time course of peak I~Ca~ in a representative wt EDS ES cell--derived cardiomyocyte. Prominent inhibition of basal I~Ca~ was observed after application of carbachol (1 μM). The CCh effect could be reversed by washout. Each data point in the time course was evoked by a 20-ms depolarization from a holding potential of −50 mV to a test potential of 0 mV. The upper trace indicates the holding current. (b) A representative β1 integrin^−/−^ EDS cardiomyocyte demonstrates the absence of the CCh-induced inhibition of basal I~Ca~ (50 ms depolarization from −50 mV to 0 mV). The time of current recordings (1 and 2, inset) is indicated. (c) Percentage of wt and β1 integrin^−/−^ cardiomyocytes displaying CCh-induced inhibition of basal I~Ca~. (d) I~Ca~ density in wt cells with CCh response. (e) I~Ca~ density in β1 integrin^−/−^ cells in absence and presence of CCh. (f) Traces (left) and I/V relationship (right) of I~Ca~ recorded in an ES cell--derived EDS β1 integrin^−/−^ cardiomyocyte (1, control; 2, in presence of CCh). I~Ca~ was evoked by 50-ms depolarizations from −40 mV to +40 mV in 10-mV increments (holding potential, −50 mV). \*Indicates statistical significance (paired *t* test, p-value \< 0.05).](0103011f1){#fig1}

**β**-adrenoceptor--mediated stimulation of I~Ca~ was preserved in **β**1 integrin**^−^** ^/**−**^ cardiomyocytes
-----------------------------------------------------------------------------------------------------------------

The absence of muscarinic signaling could be explained by perturbed intracellular signaling components including AC, cAMP, or protein kinase A. Therefore, we determined whether additional regulatory pathways, and in particular the β-adrenoceptor--mediated stimulation of I~Ca~, were defective in β1 integrin^−/−^ cardiomyocytes. All wild-type (wt) late developmental stage (LDS) cardiomyocytes exhibited an increased current density (41.4 ± 6.8%, *n* = 11; [Fig. 2](#fig2){ref-type="fig"} , a and d) after prestimulation with the β-adrenoceptor agonist isoprenaline (ISO) (0.1 μM). Similarly, ISO increased the I~Ca~ density by 64.6 ± 12% (*n* = 20) in all β1 integrin^−/−^ cardiomyocytes tested ([Fig. 2, b and e](#fig2){ref-type="fig"}). This ISO-induced upregulation of I~Ca~ was accompanied by a slight left shift in the I/V relationship (*n* = 5). However, superfusion with varying concentrations (1--10 μM) of CCh after β-adrenergic prestimulation did not suppress I~Ca~ in these cardiomyocytes (*n* = 20; [Fig. 2, c and e](#fig2){ref-type="fig"}). By contrast, CCh-inhibited ISO prestimulated I~Ca~ by 37.3 ± 7% (*n* = 11; [Fig. 2](#fig2){ref-type="fig"} c) in 82% of wt LDS cells.

![**Absence of muscarinic inhibition of ISO-prestimulated I~Ca~ in** β**1 integrin** ^−^ **/**− **ES cell--derived cardiomyocytes.** (a) I~Ca~ in a representative wt LDS ES cell--derived cardiomyocyte demonstrated prominent stimulation by ISO (0.1 μM) and subsequent inhibition by CCh. The CCh effect was reversed by ISO washout. (b) I~Ca~ in a representative β1 integrin^−/−^ ES cell--derived LDS cardiomyocyte displayed strong stimulation by ISO; however, no inhibition by subsequent application of CCh was observed. (c) Percentage of wt and β1 integrin^−/−^ cardiomyocytes displaying CCh-induced depression of ISO-prestimulated I~Ca~. (d) I~Ca~ density in wt cells with ISO and CCh response. (e) I~Ca~ density in β1 integrin^−/−^ cells exposed to ISO and CCh. (f--g) Immunostaining for Gα~i~ expression in wt (f) and β1 integrin^−/−^ ES cell--derived cardiomyocytes (g). \*Indicates statistical significance (paired *t* test, p-value \< 0.05). Bar, 25 μM.](0103011f2){#fig2}

To address whether the signaling defect was caused by a quantitative reduction of muscarinic receptors, \[^3^H\]QNB saturation binding studies were performed. There were no differences in the *B* ~max~ values for β integrin^−/−^ (33.7 ± 1.3 fmol/mg membrane protein) and wt ES cells (33.3 ± 3.1 fmol/mg membrane protein); therefore, a change in total muscarinic binding sites was excluded. Furthermore, immunocytochemical studies proved that Gα~i~ is expressed in both, wt ([Fig. 2](#fig2){ref-type="fig"} f) and β1 integrin^−/−^ ([Fig. 2](#fig2){ref-type="fig"} g) cardiomyocytes.

Muscarinic signaling was restored in **β**1 integrin rescue ES cell--derived cardiomyocytes
-------------------------------------------------------------------------------------------

To confirm that the muscarinic signaling defect was evoked specifically by the absence of the β1 integrin gene, we next investigated the hormonal modulation of I~Ca~ in β1 integrin rescue ES cell--derived cardiomyocytes. As depicted in [Fig. 3](#fig3){ref-type="fig"} a, muscarinic receptor activation inhibited basal I~Ca~ by 32.3 ± 6% ([Fig. 3](#fig3){ref-type="fig"} d) in almost half (42%, *n* = 19; [Fig. 3](#fig3){ref-type="fig"} d) of the EDS cells. In 36% (*n* = 33; [Fig. 3](#fig3){ref-type="fig"} c) of the LDS β1 integrin rescue cardiomyocytes, CCh (1-10 μM) suppressed ISO prestimulated I~Ca~ by 21 ± 6% ([Fig. 3, b and d](#fig3){ref-type="fig"}). The reduction in muscarinic inhibition and altered morphology of β1 integrin reconstituted cells (see [Fig. 5](#fig5){ref-type="fig"} i) suggests that the rescue was incomplete.

![**Muscarinic modulation of I~Ca~ is restored in** β**1 integrin rescue ES cell--derived cardiomyocytes.** Other signaling cascades are intact in β1 integrin^−/−^ ES cell--derived cardiomyocytes. (a) Basal I~Ca~ in a representative β1 integrin rescue EDS cardiomyocyte was inhibited by CCh. The CCh effect could be reversed by wash out. (b) ISO-prestimulated I~Ca~ in a representative β1 integrin rescue LDS cardiomyocyte was depressed by CCh. The CCh effect was reversed by ISO washout. (c) Percentage of β1 integrin rescue EDS and LDS cardiomyocytes responding to application of CCh or ISO and CCh. (d) Statistical analysis of I~Ca~ density in β1 integrin rescue EDS and LDS cardiomyocytes with CCh or ISO and CCh responses. (e) The NOS inhibitor L-NMMA (0.2 mM) augmented basal I~Ca~ in β1 integrin^−/−^ EDS cardiomyocytes. This effect could be partially reversed by agonist wash out. (f) Atrial natriuretic peptide (ANP; 0.1 μM) induced a prominent depression of I~Ca~ in β1 integrin^−/−^ LDS cells. \*Indicates statistically significant difference (paired *t* test, p-value \< 0.05).](0103011f3){#fig3}

![**Distribution pattern of G**α**~i~ in wt,** β**1 integrin** ^−^ **/**−**,** β**1-integrin rescue, and cytochalasin D--treated cardiomyocytes.** (a, b, and f) Deconvolution microscopy was used to characterize the distribution pattern of Gα~i~ in wt (a), β1 integrin^−/−^ (b), and cytochalasin D--treated (10--20 μM for 4 h) cardiomyocytes (f). (e) Distribution of Gα~i~ in β1 integrin rescue cardiomyocytes. (c and d) Gα~s~ staining in wt (c) and β1 integrin^−/−^ cardiomyocytes (d). (g, h, and i) DIC images of wt (g), β1 integrin^−/−^ (h), and β1 integrin rescue (i) cardiomyocytes. Bars: (a--f) 5 μm; (g--i) 25 μm.](0103011f5){#fig5}

Hence, functional responses suggest that β1 integrin deletion resulted in a selective loss of muscarinic modulation of both, basal and ISO-prestimulated I~Ca~, which could be restored upon reexpression of β1 integrins.

Nitric oxide and atrial natriuretic peptide--mediated depression of I~Ca~ is functionally intact in **β**1 integrin**^−^** ^/**−**^ cardiomyocytes
--------------------------------------------------------------------------------------------------------------------------------------------------

We next asked whether other signaling pathways involved in the regulation of I~Ca~ besides the β-adrenoceptor were affected by the β1 integrin deficit. Previous work in our group demonstrated constitutive nitric oxide synthase (NOS) 2 activity in EDS cells ([@bib18]). Consistent with this observation, the NOS inhibitor *N*-methyl-[l]{.smallcaps}-arginine (L-NMMA, 0.2 mM) enhanced I~Ca~ by 30 ± 4% in the majority (75%, *n* = 8) of β1 integrin^−/−^ EDS cells tested ([Fig. 3](#fig3){ref-type="fig"} e). Similarly, as described for wt cardiomyocytes ([@bib18]; [@bib24]), application of the nonselective phosphodiesterase (PDE) inhibitor isobutylmethylxanthine (0.2 mM) increased the I~Ca~ density by 67.4 ± 7% (*n* = 7) in β1 integrin^−/−^ EDS, and by 41.9 ± 7% (*n* = 8) in β1 integrin^−/−^ LDS cardiomyocytes. The PDE2 subtype-specific antagonist erythro-9-(2-hydroxyl-3-nonyl)adenine (30 μM) also increased I~Ca~ density by 28.4 ± 5% (*n* = 7) in β1 integrin^−/−^ EDS cardiomyocytes. Together, these findings demonstrate that these principal signaling cascades remained intact in β1 integrin^−/−^ cardiomyocytes. By contrast to the missing CCh effect, atrial natriuretic peptide (ANP; rat fragment 3--28, 0.1 μM) depressed basal I~Ca~ density by 31.9 ± 3.9% (*n* = 8) in β1 integrin^−/−^ cardiomyocytes ([Fig. 3](#fig3){ref-type="fig"} f) as previously reported for wt ES cell--derived cardiomyocytes ([@bib18]).

The defect in muscarinic signaling was found to reside at the G protein level
-----------------------------------------------------------------------------

M2 receptor expression and key intracellular signaling cascades appeared intact in β1 integrin^−/−^ cardiomyocytes. Therefore, we next examined whether the signaling defect was related to dysfunction of the pertussis toxin--sensitive G protein G~i~. We previously reported that intracellular application of GTP-γ-S in guinea pig cardiomyocytes resulted in a slight stimulation of I~Ca~ ([@bib12]), due to the opposing action of G~s~ and G~i~ proteins. [Fig. 4](#fig4){ref-type="fig"} demonstrates that GTP-γ-S induced a small increase in I~Ca~ by 35.9 ± 18% (*n* = 11; [Fig. 4, c and d](#fig4){ref-type="fig"}) in wt LDS cardiomyocytes. Similarly, in integrin-reconstituted ES cell--derived cardiomyocytes, GTP-γ-S induced a small increase (46 ± 18.5%, *n* = 4) of I~Ca~ (data not shown). By contrast, GTP-γ-S caused a significant augmentation of I~Ca~ density (130.4 ± 37%, *n* = 12; [Fig. 4](#fig4){ref-type="fig"}, b--d) in β1 integrin^−/−^ LDS cardiomyocytes that otherwise declined steadily in the absence of GTP-γ-S ([Fig. 4](#fig4){ref-type="fig"} a). This suggests that the predominant action of GTP-γ-S is to activate G~s~ and that the β1 integrin-related signaling defect is due to a disturbance in G protein signaling.

![**Role of G proteins in the muscarinic signaling defect.** (a and b) Time course of peak I~Ca~ in a representative β1 integrin^−/−^ LDS cardiomyocyte in the absence (a) or presence (b) of GTP-γ-S (0.3 mM) in the patch pipette. (c) Current density of control I~Ca~ after break in and upon maximal stimulation by GTP-γ-S in wt and β1 integrin^−/−^ cardiomyocytes. (d) The percentage increase in I~Ca~ was significantly greater in the β1 integrin^−/−^ cardiomyocytes. \*Indicates statistically significant difference (unpaired *t* test, p-value \< 0.05). (e) I~K,ACh~ activation by GTP-γ-S (0.3 mM) was observed in a wt ES cell--derived cardiomyocyte (1) but not in a β1 integrin^−/−^ cardiomyocyte (2). Representative background subtracted current ramp recordings are shown.](0103011f4){#fig4}

Unlike adult cardiomyocytes, EDS and LDS cells did not respond to agonists of other G~i~-coupled receptors including adenosine or somatostatin. Therefore, we used GTP-γ-S--mediated activation of I~K,ACh~ to examine G~i~-coupling pathways. Although I~K,ACh~ could be activated in wt (*n* = 14) and β1 integrin rescue cells (*n* = 4, data not shown), no GTP-γ-S--evoked activation of I~K,ACh~ could be observed in β1 integrin^−/−^ cardiomyocytes (*n* = 14), consistent with the effect on I~Ca~ regulation.

G**α** ~i~ distribution is altered in **β**1 integrin**^−^** ^/**−**^ ES cell--derived cardiomyocytes
-----------------------------------------------------------------------------------------------------

Immunostaining was used to investigate the patterns of G protein expression. Antibodies against G~α~ subunits were used because of the large number of possible β and γ subunits that could be involved in receptor coupling. Differences in the cellular distribution of Gα~i~ and Gα~s~, Gα~o~, the M2 receptor, and L-type Ca^2+^ channels (VDCC) (data not shown) were found in wt cells. The vast majority of murine embryonic (68.2 ± 11.7%, *n* = 489) and wt ES cell--derived (64.0 ± 24.0%, *n* = 210) cardiomyocytes displayed a network-like pattern of Gα~i~ expression, whereas relatively few (20.8 ± 3.6%, *n* = 441) β1 integrin^−/−^ cardiomyocytes displayed this pattern. Consistent with this finding, nearly all cells in whole embryoid bodies (EBs) (90.8 ± 7.9%, *n* = 1,000, five experiments) exhibited a linear network-like distribution pattern of Gα~i~ expression, whereas few (10.5 ± 6.1%, *n* = 800, 4 experiments) β1 integrin^−/−^ EBs had this pattern.

We next investigated the subcellular distribution of these G proteins at higher resolution using deconvolution microscopy. Cardiomyocytes, which were identified by α-actinin staining ([@bib22]), exhibited a linear- and network-like distribution pattern of Gα~i~ in wt ([Fig. 5](#fig5){ref-type="fig"} a) cells and diffuse staining of Gα~s~ in the wt ([Fig. 5](#fig5){ref-type="fig"} c) cells. β1 integrin^−/−^ ES cell--derived cardiomyocytes exhibited diffuse staining for Gα~i~ ([Fig. 5](#fig5){ref-type="fig"} b) and Gα~s~ ([Fig. 5](#fig5){ref-type="fig"} d). Consistent with our functional results, a network-like distribution was also observed in the β1 integrin rescue cells ([Fig. 5](#fig5){ref-type="fig"} e), whereas Gα~o~ was diffusely distributed throughout all cells (data not shown). In addition to distinct patterns of Gα~i~ distribution, β1 integrin^−/−^ ES cell--derived cardiomyocytes had different shapes as compared with the wt ([Fig. 5, g and h](#fig5){ref-type="fig"}) ([@bib9]). β1 integrin rescue cells showed a partial morphological reversal ([Fig. 5](#fig5){ref-type="fig"} i).

Together, these findings are consistent with the electrophysiological results, which suggest that G~i~ underlies the muscarinic signaling defect.

G**α** ~i~ colocalizes with focal contact proteins
--------------------------------------------------

A similar network-like distribution of Gα~i~ has been reported for β1 integrin focal adhesion--associated molecules such as talin and vinculin ([@bib23]; [@bib16]). We have identified a unique architecture for Gα~i~ in the β1 integrin^−/−^ cells and found that talin and vinculin exhibit a similar diffuse distribution as Gα~i~ (data not shown). We subsequently analyzed the interaction between β1 integrins, talin, and vinculin with Gα~i~ using deconvolution and electron microscopy. These approaches failed to demonstrate a close colocalization of β1 integrins and Gα~i~ ([Fig. 6](#fig6){ref-type="fig"} a). Deconvolution microscopy did reveal, however, spatial colocalization between Gα~i~ and both vinculin and talin ([Fig. 6, b and c](#fig6){ref-type="fig"}) in wt cells. Electron microscopy of double immunogold--labeled cells further revealed a relatively close colocalization between Gα~i~ and vinculin (40--150 nm) in embryonic ([Fig. 6](#fig6){ref-type="fig"} d) and adult mouse/rat cardiomyocytes ([Fig. 6](#fig6){ref-type="fig"} e), suggesting that direct protein--protein interaction is highly unlikely.

![**G**α**~i~, talin, and vinculin colocalize in wt cells.** (a and b) Deconvolution microscopy of ES cell--derived cells exhibited no overlap of Gα~i~ and β1 integrins (a), but colocalization of Gα~i~ and talin (b). (c) Higher magnification showing colocalization of Gα~i~ and talin. (d and e) Immunogold staining for Gα~i~ and vinculin in murine embryonic cardiomyocytes (d) and in adult mouse heart (e). Vinculin and Gα~i~ were labeled with 5- and 15-nm gold particles, respectively. The distance between pairs of gold particles was 40--150 nm. Bars: (a and b) 6 μm; (c) 2.5 μm; (d and e) 90 nm.](0103011f6){#fig6}

Cytochalasin D recapitulates the functional and morphological changes induced by **β**1 integrin deficiency
-----------------------------------------------------------------------------------------------------------

To further test whether muscarinic signaling is dependent on the integrity of the cytoskeleton, isolated murine embryonic cardiomyocytes (E11.5, E17.5) were incubated with cytochalasin D (10--20 μM) to immobilize the cytoskeleton. Cytochalasin D--treated cardiomyocytes (E11.5) displayed fast run down of I~Ca~, and the majority (85.7%) of cells tested were unresponsive to CCh (*n* = 21). By contrast, CCh depressed basal I~Ca~ by 45.7 ± 3% (*n* = 5) in 60% of untreated cells. ISO-mediated stimulation of I~Ca~ remained intact in cytochalasin D pretreated murine cardiomyocytes (*n* = 5, E17.5). Cytochalasin D treatment also induced a diffuse distribution of Gα~i~ in both, ES cell--derived cells and murine embryonic cardiomyocytes ([Fig. 5](#fig5){ref-type="fig"} f), consistent with the pattern observed in the β1 integrin^−/−^ cardiomyocytes.

Discussion
==========

In this study, we provide evidence that β1 integrin deletion results in a selective loss of muscarinic signaling in cardiomyocytes. This signaling defect is clearly related to the lack of β1 integrins because reconstitution with β1 integrins reversed the altered morphology and the muscarinic signaling in β1 integrin^−/−^ ES cells.

Evidence for G~i~ dysfunction in **β**1 integrin**^−^** ^/**−**^ cardiomyocytes
-------------------------------------------------------------------------------

To date, β integrins have been shown to play an important role primarily in tyrosine kinase--mediated signaling (see for review [@bib27]). Furthermore, integrin-dependent cell anchorage regulates the efficiency of signaling from G protein--coupled receptors ([@bib31]). In β1 integrin^−/−^ cardiomyocytes, except for an absence of muscarinic regulation of I~Ca~ and I~K,ACh~, no other signaling defects could be detected. Our functional data pinpoint the signaling defect at the level of G~i~, as intracellular dialysis with GTP-γ-S resulted in pronounced enhancement of G~s~-mediated stimulation of I~Ca~ and defective activation of I~K,ACh~ in the β1 integrin^−/−^ cardiomyocytes. In previous investigations, antibody neturalization of integrins in situ revealed a role for integrins in the modulation of I~Ca~ or I~Ba~ ([@bib43]). A recent study found that cat cardiomyocytes cultured on laminin-coated cover slips had disturbed cholinergic and β-adrenergic responses ([@bib39],[@bib40]). These data are consistent with our findings and indicate a critical role for integrins in both receptor coupling and ion channel modulation. [@bib4] suggested that changes in integrin matrix interactions might underlie defects in signaling molecule clustering. Herein, we provide mechanistic evidence that receptor expression remains unchanged upon β1 integrin deletion; however, the altered distribution pattern of G~i~ proteins is observed only under conditions that also result in a muscarinic signaling defect.

Role of the cytoskeleton in G protein function
----------------------------------------------

Our work also demonstrates a focal adhesion--related intracellular distribution for Gα~i~, but not Gα~s~, and Gα~o~. The idea that components of the cytoskeleton can determine G protein localization and function (for review see [@bib17]) has been proposed before by [@bib35] and [@bib15] who found a direct association between the γ12 subunit and between Gα~q~/Gα~11~ and actin filaments, respectively. Furthermore, the activation and release of Gα~i2~ from the cytoskeleton has been reported ([@bib29]). Consistent with our functional findings, the subcellular distribution of Gα~i~ was severely altered by the β1 integrin deficiency in cardiomyocytes. Our findings are also consistent with previous studies using antisense approaches ([@bib20], [@bib21]), where, in contrast to G protein knock-out models ([@bib26]), selective G protein--mediated receptor--effector coupling could not be reconstituted at all by other G proteins. This is also supported by recent work, where selective G protein β/γ complexes were shown to be involved in the inhibition of neuronal Ca^2+^ channels ([@bib5]). This study suggests that the specificity of signal transduction is not only related to protein--protein interaction, but also to the spatial arrangement of signaling components.

Due to the similar cellular distribution observed for Gα~i~ and that reported for the focal contact--associated proteins talin and vinculin, we tested their spatial relation to one another in cardiomyocytes. In wt cardiomyocytes, Gα~i~ and both talin and vinculin colocalized, whereas they did not in β1 integrin^−/−^ cardiomyocytes. The association between these molecules was further demonstrated by inhibiting the polymerization of G actin to F actin with cytochalasin D ([@bib37]), which resulted in a similar alteration in cellular morphology and signaling, as observed in β1 integrin^−/−^ cells.

The parallel relationship between cellular structure and function that we observe in cardiomyocytes suggests that β1 integrins play an important role in organizing the spatial association between signaling molecules such as G~i~ and focal adhesion--associated proteins. A similar relationship was demonstrated for caveolin ([@bib1]) and PDZ domains ([@bib7]). It was proposed that anchoring proteins of the PSD-95/SAP90 family are required for G protein stimulation of the membrane-associated synaptic ion channel Kir3.2c ([@bib13]). An important role of signaling microdomains in cardiomyocytes has been demonstrated by [@bib19], who demonstrated that colocalization of AC/cAMP and PDEs leads to a tight regulated local control of the ISO-mediated upregulation of I~Ca~.

Thus, we propose that β1 integrin deletion results in altered cytoskeletal architecture due to the loss of important anchorage proteins. This causes spatial displacement of G~i~ proteins and both a physical and functional disruption of signaling microdomains.

Materials and methods
=====================

ES cell preparation
-------------------

Studies used ES cells of the D3 line (wt) ([@bib6]; [@bib42]), the heterozygous β1 integrin^+/−^ ES cell line, the β1 integrin^−/−^ ES cell line generated on D3 background ([@bib8]), and the β1 integrin rescue ES cell line. This line was generated by reexpressing β1 integrins in β1 integrin^−/−^ ES cells under control of the phosphoglycerate kinase promoter. wt and β1 integrin^+/−^ ES cells were cultured and differentiated into spontaneously beating cardiomyocytes as previously described ([@bib42]). EDS cells were derived from EBs plated for 3--4 d and LDS cells from EBs 9--12 d after plating. β1 integrin^−/−^ and β1 integrin rescue ES cells were grown on gelatin-coated cover slips without feeder cells in medium supplemented with 5 ng/ml recombinant human leukemia inhibitory factor ([@bib9]). β1 integrin^−/−^ ES cells were cultured for 3 d in hanging drops and 3 d in suspension before plating on gelatin-coated plates. Because of the delayed onset of beating, β1 integrin^−/−^ cardiomyocytes derived from EBs plated for 6--10 d were defined as EDS, and those cultured for 14--18 d were defined as LDS cells ([@bib9]). β1 integrin rescue ES cells were maintained in presence of G418 (300 μg/ml). Single cardiomyocytes were isolated from clusters of spontaneously beating areas as previously described ([@bib18]). Murine embryonic (E11.5, E17.5) ventricular cardiomyocytes were harvested from superovulated mice ([@bib10]). The heart was removed from the embryo, and the cardiomyocytes were isolated by collagenase digestion.

Cytochalasin D treatment
------------------------

∼12 h after dissociation, murine embryonic cardiomyocytes were treated with cytochalasin D for times indicated (15 min--16.5 h). Murine embryonic cells were incubated with 10 μM cytochalasin D and ES cell--derived cardiomyocytes with 20 μM cytochalasin D.

Electrophysiology
-----------------

Only spontaneously beating single cardiomyocytes were selected for patch clamp recordings as previously described ([@bib18]; [@bib38]). Whole cell or perforated patch measurements yielded similar results. Depolarizing pulses lasting 20 or 50 ms were applied at a frequency of 0.33 and 0.2 Hz, respectively, with an Axopatch 200-A (Axon Instruments, Inc.) or an EPC-9 amplifier (Heka). For most recordings, currents were leak subtracted using a P/n leak subtraction protocol (trace in [Fig. 3](#fig3){ref-type="fig"}, not leak subtracted). Data were acquired at a sampling rate of 2--10 kHz, filtered at 1 kHz, stored on hard disk, and analyzed off-line using the ISO2 (MFK) or Pulse/Pulse-Fit (Heka) software package. Analysis of the (CCh) and the ISO effects was performed as previously described. Only those cells exhibiting a change in I~Ca~ density of \>5% after ISO or CCh application were analyzed. The GTP-γ-S effect was compared with the response of untreated cells on the same experimental day. The average change in I~Ca~ density was calculated during the period of 180 s after break in (wt, *n* = 9; β1 integrin^−/−^, *n* = 10; rescue cardiomyocytes, *n* = 5) and subtracted from the GTP-γ-S response.

I~K,ACh~ recordings were made with equimolar K^+^ concentrations to increase current amplitudes and GTP-γ-S (0.3 mM) in the pipette. Voltage ramp depolarizations (150 ms, −100--80 mV) were applied at a frequency of 0.1 Hz immediately after break in. Control ramp currents obtained before current activation were subtracted from I~K,ACh~ currents, which were evident 1--2 min after membrane rupture. All currents were recorded from cells adhered to glass cover slips in a temperature-controlled (35°C) recording chamber. For I~Ca~, the internal solution contained 120 mM CsCl, 3 mM MgCl~2~, 5 mM MgATP, 10 mM EGTA, 5 mM Hepes, pH 7.4 (adjusted with CsOH), the external solution contained 120 mM NaCl, 5 mM KCl, 3.6 mM CaCl~2~, 20 mM TEA-Cl, 1 mM MgCl~2~, 10 mM Hepes, pH 7.4 (adjusted with TEA-OH). For I~K,ACh~, the internal solution contained 40 mM KCl, 100 mM kaspartate, 5 mM MgATP, 2 mM EGTA, and 10 mM Hepes (pH adjusted to 7.4 with KOH), and the extracellular solution contained 140 mM KCl, 2 mM MgCl~2~, 5 mM NaCl, 1.8 mM CaCl~2~, 5 mM glucose, and 5 mM Hepes (pH adjusted to 7.4 with KOH). For perforated patch clamp recordings, amphotericin B (Sigma-Aldrich) was dissolved in DMSO and used at a final concentration of 250--500 μg/ml. Current measurements were initiated after the series resistance reached 10--20 MΩ. All substances were obtained from Sigma-Aldrich.

Data are expressed as mean ± SEM, paired or unpaired Student\'s *t* test was used to analyze electrophysiological data, and a p-value of \<0.05 was considered significant.

Radioligand binding assays
--------------------------

EBs were harvested, and membrane homogenates were prepared. In brief, homogenates were incubated for 3 h at 22°C in 25 mM sodium phosphate (pH 7.4) containing 5 mM MgCl~2~. Saturation binding experiments were carried out with (-)-\[^3^H\]*N*-quinuclidinyl benzilate (\[-\]-\[^3^H\]QNB; 42.0 Ci/mmol; NEN Life Science Products). Binding was performed with saturating concentrations of each radioligand (2 nM), and nonspecific binding was defined as binding in the presence of 2.5 μM atropine. Protein concentrations were determined by the Bradford method.

Immunocytochemistry
-------------------

Whole EBs, EB and murine embryonic heart-derived isolated cells were incubated overnight with antibodies at 4°C. Antibodies included mouse anti--rat actinin (1:800; Sigma-Aldrich), monoclonal antitalin or antivinculin (1:100; Chemicon International), polyclonal rat anti--mouse β1 integrin (Sigma-Aldrich), rabbit polyclonal anti-M2 receptor (1:2,000; R&D Systems), α1C (1:200; Alomone Labs), and anti--G protein α-subunits. G protein antibodies against Gα~i1--3,~ Gα~o~, and Gα~s~ subunits (Santa Cruz Biotechnology, Inc.) were used at a 1:500 dilution. Next, cells were stained with Cy3- (or Cy2-) conjugated goat anti--rabbit (or goat anti--mouse) Ig (1:800, Sigma-Aldrich) and with a biotinylated goat anti--mouse (or anti--rabbit) IgG (1:400, Dako) or a biotinylated anti--rat antibody (Amersham Pharmacia Biotech) followed by streptavidin-conjugated Alexa FluorTM488 (1:200; Mo Bi Tec), streptavidin-conjugated Cy2 (1:100, Amersham Pharmacia Biotech), or Cy3 (1:600, Amersham Pharmacia Biotech).

Morphological analysis
----------------------

The distribution pattern of Gα~i~ was analyzed by fluorescence microscopy (ZEISS) in wt (EDS, 7 + 3; LDS, 7+11), β1 integrin^−/−^ (EDS, 6 + 10; LDS, 6 + 14), and murine embryonic cardiomyocytes (E11.5/12.5, E17.5). All cardiomyocytes, identified by α-actinin costaining were analyzed on each slide (ranging from 49 to 174). Statistical analysis was performed using the unpaired Student\'s *t* test. DIC pictures were taken using an appropriately equipped Axiovert 135 microscope (ZEISS).

Deconvolution microscopy
------------------------

For each specimen, an image stack (64 planes) was collected using an inverted ZEISS Axiovert 100 M with a ZEISS 63 Planapochromat oil immersion objective. Bandpass filter sets for Cy2 and Cy3 (AHF) without overlap in the fluorescence emission spectrum were used. The thickness of each optical section was 100 nm to assure appropriate optical resolution for the subsequent iterative deconvolution process. A three-dimensional deconvolution algorithm was applied to the image stacks ([@bib30]) to increase the image resolution for colocalization (KS 400; ZEISS). Both theoretical point-spread functions (PSFs) based on microscope and specimen data and measured PSFs, calculated from fluorescent beads with a diameter of 1 μm (Molecular Probes, T-14792), were used. A conjugated gradient maximum likelihood deconvolution algorithm with 60 iterations was performed on the image stacks. Output intensities were scaled between gray value 0 and 255. Generally, theoretical and measured PSFs generated comparable results with slightly higher resolution in the resulting images by using the measured PSFs.

Immunogold labeling
-------------------

Adult and embryonic mouse or rat heart tissue was perfused with 4% PFA in 0.1 M PBS or with 2% PFA/2% glutardialdehyde at 4°C. After fixation, the tissue was embedded with araldit or LR-white. The tissue grids were treated with 50 mM TBS for 15 min and blocked with 4% BSA in TBS for 1 h at room temperature. Then, primary antibodies against vinculin or talin (1:30--50) or β1 integrin (1:100; PharMingen) and a rabbit polyclonal antibody for Gα~i~ were used at room temperature for 2 h. Grids were rinsed four times with 0.05% Tween-20--TBS, incubated with 5-nm gold-conjugated anti--mouse (or anti--rabbit) IgG (1:30--50) for 1 h, and treated with biotinylated goat anti--rabbit or anti--mouse (1:50; Dako) for 1 h at room temperature. Finally, specimens were incubated with 15-nm gold-labeled streptavidin (1:30; Zymed Laboratories) for 1 h followed by 2% glutardialdehyde fixation for 10 min. For contrast, grids were treated with 2% uranylacetate in 70% ethanol for 20 min and PBS for 7 min.
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